Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data in mouse liver expressing or not the adapter Grb14

ABSTRACT: Grb14 is an endogenous inhibitor of insulin signaling We used microarrays to investigate gene expression patterns after Grb14 silencing in mouse liver

ORGANISM(S): Mus musculus

PROVIDER: GSE53521 | GEO | 2016/01/01

SECONDARY ACCESSION(S): PRJNA232271

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression data in mouse liver expressing or not the adapter Grb14

Project description:Grb14 is an endogenous inhibitor of insulin signaling We used microarrays to investigate gene expression patterns after Grb14 silencing in mouse liver

2016-10-28 | GSE81387 | GEO

Expression data in mouse liver expressing or not the adapter Grb14

Project description:Grb14 is an endogenous inhibitor of insulin signaling We used microarrays to investigate gene expression patterns after Grb14 silencing in mouse liver Ten week old mice were injected intraveinously with recombinant adenovirus expressing a control sh RNA (sh scramble) or a sh targetting Grb14 (shGrb14), and liver were studied in the fed state 7 days after the infection

2016-07-03 | E-GEOD-53521 | biostudies-arrayexpress

Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction

Project description:Insulin resistance increases patient’s risk of developing type 2 diabetes (T2D), nonalcoholic steatohepatitis (NASH) and a host of other comorbidities including cardiovascular disease and cancer. At the molecular level, insulin exerts its function through the insulin receptor (IR), a transmembrane receptor tyrosine kinase. Data from human genetic studies have shown that Grb14 functions as a negative modulator of IR activity, and germline Grb14-knockout (KO) mice have improved insulin signaling in liver and muscle tissues. Here, we show that Grb14 knockdown in the liver and the heart with an AAV-shRNA (Grb14-shRNA) improves glucose homeostasis in diet-induced obese (DIO) mice. A previous report has shown that germline deletion of Grb14 in mice results in cardiac hypertrophy and decreased systolic function, effects that could severely limit the therapeutic potential of targeting Grb14. In this report, we demonstrate that there are no significant changes in hemodynamic function as measured by echocardiography in DIO Grb14 and DIO sham mice for a period of four months. While additional studies are needed to further establish efficacy and to de-risk potential negative cardiac effects in pre-clinical heart failure models, our data support inhibiting Grb14 to treat diabetes and related conditions.

2020-04-14 | GSE143319 | GEO

Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance

Project description:Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance

| PRJNA549077 | ENA

Liver microarray from eIF6 heterozygotes or wild-type 3 weeks-old mice

Project description:Liver is primary involved in the response to insulin after feeding. Hepatocytes activates a tightly controlled genetic programme where specific sets of genes are modulates in response to insulin, for activation of the anabolic pathways. We used microarrays analysis to detail the global programme of gene expression in liver upon eIF6 haploinsufficiency and identified distinct classes of down-regulated genes and up-regulated genes during this process, that globally defines reprogramming of metabolism

2015-10-01 | GSE61053 | GEO

Liver mRNA expression in high fat diet fed mice with hepatic specific Slug knockout

Project description:Liver steatosis is a driving force for nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease, insulin resistance, and type 2 diabetes. Slug (also called Snai2 or Snail2) is a transcriptional regulator that may play a critical role in the regulation of liver function. To prove that, we used microarrays to detail the hepatic Slug regulated gene expression underlying liver steatosis and identified distinct pathways controlled by Slug during this process.

2020-02-18 | GSE145404 | GEO

Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor

Project description:In order to identify the effects of JNK inhibitor or p38 Inhibitor on the transcriptome of ATP7B H1069Q-overexpressing liver cells, we performed RNAseq experiments

2017-01-04 | GSE80361 | GEO

Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance [RNA-Seq]

Project description:Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance [RNA-Seq]

| PRJNA549079 | ENA

Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance [miRNA-Seq]

Project description:Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance [miRNA-Seq]

| PRJNA549080 | ENA

Expression data from liver, muscle and fat tissue of children with end stage liver disease

Project description:Cachexia, described as a syndrome of weight loss, muscle wasting, fat loss and insulin resistance has been described in patients with chronic liver disease. Whereas extensive work is being done to delineate these molecular pathways in adult patients with chronic liver or other disease, very little is known about these pathways in children with chronic liver disease. We used microarrays to detail the global programme of gene expression underlying the metabolic processes of cachexia in children with end stage liver disease udergoing liver transplantion. We included tissue from patients with Crigler-najjar syndrome as controls. We were able to identify distinct classes of differentially regulated genes related to these processes.

2017-07-31 | GSE84954 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data